Presentation
17 March 2023 Fluorescence conjugated anti-mucin antibodies to target and brightly label colorectal and pancreatic cancer
Author Affiliations +
Abstract
Pancreatic cancer and colon cancer metastasis are recalcitrant cancers that are often difficult to detect. Mucin 5AC (MUC5A) and Mucin 4 (MUC4) have been found to be overexpressed in pancreatic and colon cancers, respectively, while having minimal expression in normal tissue. Using Mucin antibodies conjugated to a fluorescent dye, we demonstrate their specific labeling of human derived pancreatic and colon cancers in both subcutaneous and orthotopic mouse models. Tumor-specific fluorescent antibodies are clinically promising tools for improving both oncologic resection and patient survival.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Kristin E. Cox, Michael A. Turner, Siamak Amirfakhri, Thinzar M. Lwin, Shanglei Liu, Robert M. Hoffman, Surinder K. Batra, and Michael Bouvet "Fluorescence conjugated anti-mucin antibodies to target and brightly label colorectal and pancreatic cancer", Proc. SPIE PC12361, Molecular-Guided Surgery: Molecules, Devices, and Applications IX, PC123610I (17 March 2023); https://doi.org/10.1117/12.2650520
Advertisement
Advertisement
KEYWORDS
Pancreatic cancer

Luminescence

Colorectal cancer

Mouse models

Tumors

Cancer

Colon

Back to Top